Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider

BACKGROUND: Acromegaly patients, even those with IGF-1 values within the normal range receiving somatostatin receptor ligands (SRLs), often suffer from significant symptoms. It is not known to what extent patients’ medical providers are aware of the frequency and severity of acromegaly symptoms or l...

Descripción completa

Detalles Bibliográficos
Autores principales: Geer, Eliza B., Sisco, Jill, Adelman, Daphne T., Ludlam, William H., Haviv, Asi, Gelbaum, Dana, Liu, Shuqian, Mathias, Susan D., Shi, Lizheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066283/
https://www.ncbi.nlm.nih.gov/pubmed/31808101
http://dx.doi.org/10.1007/s11102-019-01013-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066283/
https://www.ncbi.nlm.nih.gov/pubmed/31808101
http://dx.doi.org/10.1007/s11102-019-01013-2

Ejemplares similares